Pharvaris B.V.

PHVS54

$19.84arrow_drop_down4.47%-$0.94

PHVS54

$19.84

arrow_drop_down4.47%-$0.94

Performance History

Key Stats
Open	$22.87
Prev. Close	$22.61
EPS	-2.80
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	21.19	23.66
52 Week Range	15.00	33.00

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.80

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Pharvaris B.V. (PHVS)

Pharvaris B.V. (PHVS) is a pharmaceutical company that focuses on the development and commercialization of novel therapies for the treatment of hereditary angioedema (HAE) and other rare diseases. The company's primary product candidate, PHA121, is a subcutaneously administered small molecule bradykinin B2 receptor antagonist being developed as an on-demand therapy for the acute treatment of HAE attacks. PHA121 has the potential to be a significant advancement in the treatment of HAE, as it can rapidly and effectively block the bradykinin B2 receptor, which is responsible for the symptoms of an HAE attack.

The stock price history of Pharvaris B.V. (PHVS) has been relatively stable since its initial public offering (IPO) in 2021. The company's stock has traded within a range of $XX to $XX over the past year, with an average daily trading volume of XX million shares. Despite the stability in stock price, there have been several notable events that have impacted Pharvaris B.V.'s market cap and investor sentiment.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Berndt Axel Edvard Modig CPA, M.B.A., MBA
Headquarters: Leiden
Employees: 68
Exchange: NASDAQ

Keep an eye on Pharvaris B.V.

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Pharvaris B.V.'s (PHVS) price per share?

The current price per share for Pharvaris B.V. (PHVS) is $19.84. The stock has seen a price change of -$0.95 recently, indicating a -4.47% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Pharvaris B.V. (PHVS)?

For Pharvaris B.V. (PHVS), the 52-week high is $33, which is 66.29% from the current price. The 52-week low is $15, the current price is 32.3% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Pharvaris B.V. (PHVS) a growth stock?

Pharvaris B.V. (PHVS) has shown an average price growth of -3.67% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pharvaris B.V. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Pharvaris B.V. (PHVS) stock price performance year to date (YTD)?

As of the latest data, Pharvaris B.V. (PHVS) has a year-to-date price change of -23.29%. Over the past month, the stock has experienced a price change of 0.58%. Over the last three months, the change has been 26.16%. Over the past six months, the figure is -6.26%.

help

Is Pharvaris B.V. (PHVS) a profitable company?

Pharvaris B.V. (PHVS) has a net income of -$98.81M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$96.91M. Furthermore, the EBITDA is -$123.73M.

help

What is the market capitalization of Pharvaris B.V. (PHVS)?

Pharvaris B.V. (PHVS) has a market capitalization of $1.07B. The average daily trading volume is 20.41, indicating the stock's liquidity and investor engagement.